next choice- levonorgestrel tablet
rebel distributors corp. - levonorgestrel (unii: 5w7sia7yzw) (levonorgestrel - unii:5w7sia7yzw) - levonorgestrel 0.75 mg - levonorgestrel tablets are a prescription-only emergency contraceptive, for women age 17 and younger, that can be used to prevent pregnancy following unprotected intercourse or a known or suspected contraceptive failure. this product is not approved for nonprescription use. to obtain optimal efficacy, the first tablet should be taken as soon as possible within 72 hours of intercourse. the second tablet must be taken 12 hours later. progestin-only contraceptive pills (pops) are used as a routine method of birth control over longer periods of time, and are contraindicated in some conditions. it is not known whether these same conditions apply to the levonorgestrel tablets regimen consisting of the emergency use of two progestin pills. pops however, are not recommended for use in the following conditions: - known or suspected pregnancy known or suspected pregnancy - hypersensitivity to any component of the product hypersensitivity to any component of the product there is no information about dependence assoc
levonorgestrel tablet
lotus pharmaceutical co., ltd. nantou plant - levonorgestrel (unii: 5w7sia7yzw) (levonorgestrel - unii:5w7sia7yzw) - levonorgestrel tablets are a progestin-only emergency contraceptive indicated for prevention of pregnancy following unprotected intercourse or a known or suspected contraceptive failure. to obtain optimal efficacy, the first tablet should be taken as soon as possible within 72 hours of intercourse. the second tablet should be taken 12 hours later. levonorgestrel tablets are available only by prescription for women younger than age 17 years, and available over the counter for women 17 years and older. levonorgestrel tablets are not indicated for routine use as a contraceptive. levonorgestrel tablets are contraindicated for use in the case of known or suspected pregnancy. many studies have found no harmful effects on fetal development associated with long-term use of contraceptive doses of oral progestins. the few studies of infant growth and development that have been conducted with progestin-only pills have not demonstrated significant adverse effects. in general, no adverse effects of progestin-only pills ha
darvon-n- propoxyphene napsylate tablet, film coated
stat rx usa - propoxyphene napsylate (unii: 38m219l1oj) (propoxyphene - unii:s2f83w92tk) - propoxyphene napsylate 100 mg - darvon-n is indicated for the relief of mild to moderate pain. darvon-n is contraindicated in patients with known hypersensitivity to propoxyphene. darvon-n is contraindicated in patients with significant respiratory depression (in unmonitored settings or the absence of resuscitative equipment) and patients with acute or severe asthma or hypercarbia. darvon-n is contraindicated in any patient who has or is suspected of having paralytic ileus. darvon-n is a schedule iv narcotic under the u.s. controlled substances act. darvon-n can produce drug dependence of the morphine type, and therefore, has the potential for being abused. psychic dependence, physical dependence and tolerance may develop upon repeated administration. darvon-n should be prescribed and administered with the same degree of caution appropriate to the use of other narcotic-containing medications. since darvon-n is a mu-opioid agonist, it may be subject to misuse, abuse, and addiction. addiction to opioids prescribed for pain manageme
vonvendi powder for solution
takeda canada inc - von willebrand factor (recombinant) - powder for solution - 650unit - von willebrand factor (recombinant) 650unit - hemostatics
vonvendi powder for solution
takeda canada inc - von willebrand factor (recombinant) - powder for solution - 1300unit - von willebrand factor (recombinant) 1300unit - hemostatics
levonorgestrel tablets, 0.75mg
lupin limited - levonorgestrel - tablet - 0.75mg - levonorgestrel 0.75mg - contraceptives
humate-p (antihemophilic factor/von willebrand factor complex- human kit
csl behring gmbh - human coagulation factor viii/von willebrand factor complex (unii: 5t6b772r4q) (human coagulation factor viii/von willebrand factor complex - unii:5t6b772r4q) - human coagulation factor viii/von willebrand factor complex 80 [iu] in 1 ml - humate-p, antihemophilic factor/von willebrand factor complex (human), is indicated for treatment and prevention of bleeding in adults with hemophilia a (classical hemophilia). humate-p is also indicated in adult and pediatric patients with von willebrand disease (vwd) for: controlled clinical trials to evaluate the safety and efficacy of prophylactic dosing with humate-p to prevent spontaneous bleeding have not been conducted in vwd subjects [see clinical studies (14)]. humate-p is contraindicated in individuals who have had an anaphylactic or severe systemic reaction to antihemophilic factor or von willebrand factor preparations. animal reproduction studies have not been conducted with humate-p. it is also not known whether humate-p can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. humate-p should be given to a pregnant woman only if clearly needed. it is not known whether humate-p can cause harm to the mother or the fetus when administered during labor and deli
levonelle one step 1.5mg tablets
bayer plc - levonorgestrel - oral tablet - 1.5mg
levonelle 1500microgram tablets
bayer plc - levonorgestrel - oral tablet - 1.5mg
levonorgestrel tablet
hra pharma america, inc. - levonorgestrel (unii: 5w7sia7yzw) (levonorgestrel - unii:5w7sia7yzw) - use for women to reduce chance of pregnancy after unprotected sex (if a contraceptive failed or if you did not use birth control) - if you are already pregnant (because it will not work) - for regular birth control